Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

PAR-23-065: NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

Closed Closed January 7, 2026 Opportunity PAR-23-065

This grant is closed. A newer notice from the same program is open now: NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) (PAR-27-083). Status: Due dates in the notice, expires May 25, 2029. It is in our archive of National Institutes of Health notices from 2022.

National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on January 7, 2026.

From the official notice on Grants.gov, last changed November 23, 2022. Checked November 7, 2026.

About this NIH notice

Projects funded under PAR-23-065 were run by National Institute of Allergy and Infectious Diseases (NIAID, 30 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.

Application due dates, page limits and budget limits are set in the notice. Read PAR-23-065 in the NIH Guide.

Other notices with this title

National Institutes of Health has posted this title under other numbers: earlier or later rounds, or the same competition for another area. Each has its own dates and may change its rules.

NoticePostedDeadlineStatus
PAR-27-083May 7, 2026Due dates in the notice, expires May 25, 2029Open

Key dates

PostedNovember 23, 2022
DeadlineJanuary 7, 2026
Archived by Grants.govFebruary 12, 2026

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

All 15 applicant types the notice lists

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

What the grant funds

This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID), invites applications for investigator-initiated Resource-Related Research Projects (R24). The proposed resource must provide a significant benefit to currently funded high priority projects in need of further coordination and support in the areas specified. Under rare circumstances, this mechanism may be used to support development of a new resource to the broader scientific community of the NIAID. It is anticipated that the request for resource support through the R24 activity code will occur on an infrequent basis and only in circumstances where other mechanisms of support from the NIAID are not appropriate. The proposed resources should be relevant to the scientific areas of the NIAID mission including the biology, pathogenesis, and host response to microbes, including HIV; the mechanisms of normal immune function and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious, immune-mediated, and allergic diseases.

Category: Health.

Funded under PAR-23-065 so far

NIH funded 30 projects under PAR-23-065 in fiscal 2024 to 2026, at 23 institutions. The median yearly award was $812,765.

Most projects: University of Alabama at Birmingham (Alabama), 4, Johns Hopkins University (Maryland), 3, Harvard Medical School (Massachusetts), 2, University of California, San Francisco (California), 2, University of Texas Med BR Galveston (Texas), 1.

Recently funded projects
ProjectInstitutionFiscal yearAward
Resource of Functional Genomics Screening Platforms R24Harvard Medical School2026$635,073
Support for Emerging Virus and Arbovirus Research R24University of Texas Med BR Galveston2026$807,498
The San Diego Implementation Science Hub to Advance HIV Research and Impact Using Implementation Science and Practice R24University of California, San Diego2026$691,829
CFAR Network of Integrated Clinical Systems (CNICS) R24University of Alabama at Birmingham2026$8.4 million
Virus Taxonomy: A Community Knowledgebase Supporting Virus Research R24University of Alabama at Birmingham2026$744,991
Production and Distribution of Filarial Research Reagents R24University of Georgia2026$1.0 million
Centralized Resource to Accurately Quantify Latent and Expressed HIVReservoirs R24Accelevir Diagnostics, LLC2026$764,899
HIV Implementation Science Coordination Initiative R24Northwestern University2026$749,549

From NIH RePORTER, which lists each project once per fiscal year it was funded. Amounts are the yearly award.

Who has won Allergy and Infectious Diseases Research grants before

From fiscal 2021 to 2025, Allergy and Infectious Diseases Research (93.855) awarded $22 billion across 13,282 grant awards, an average of $1.6 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
Fred Hutchinson Cancer CenterWashington85$938 million
Duke UniversityNorth Carolina230$781 million
University of California, Los AngelesCalifornia138$745 million
The Johns Hopkins UniversityMaryland321$668 million
Emory UniversityGeorgia282$650 million

Top states: California ($3.4 billion), Massachusetts ($2.1 billion), Washington ($1.9 billion), New York ($1.8 billion), North Carolina ($1.5 billion).

Applying now

This notice no longer takes applications. Apply under the newer notice, PAR-27-083, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is PAR-23-065 still open?

No. It closed on January 7, 2026. A newer notice is open: PAR-27-083, due dates in the notice, expires May 25, 2029.

Who can apply for NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)?

Closed January 7, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

Who has been funded under PAR-23-065?

NIH RePORTER lists 30 projects funded under PAR-23-065 in fiscal 2024 to 2026, at 23 institutions. The most were at University of Alabama at Birmingham, Johns Hopkins University, Harvard Medical School.

Who has won Allergy and Infectious Diseases Research grants before?

The largest recipients over five fiscal years were Fred Hutchinson Cancer Center, Duke University, University of California, Los Angeles. The program made 13,282 awards worth $22 billion in that time.

Similar open grants